Researcher profile · Semantic Scholar

Vian Azzu

h-index: 16
Works: 36
Citations: 1,454

Most-cited papers

Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease.
Vian Azzu, M. Vacca, S. Virtue, M. Allison +1 more
2020Gastroenterology327 citations Open access
Semantic Scholar
The on/off switches of the mitochondrial uncoupling proteins
Vian Azzu, M. Brand
2009TIBS -Trends in Biochemical Sciences. Regular ed239 citations Open access
Semantic Scholar
The regulation and turnover of mitochondrial uncoupling proteins
Vian Azzu, M. Jastroch, Ajit S. Divakaruni, M. Brand
2010Biochimica et Biophysica Acta142 citations Open access
Semantic Scholar
Degradation of an intramitochondrial protein by the cytosolic proteasome
Vian Azzu, M. Brand
2010Journal of Cell Science125 citations Open access
Semantic Scholar
Energy Metabolism and Ageing in the Mouse: A Mini-Review
Vian Azzu, T. Valencak
2017Gerontology88 citations Open access
Semantic Scholar
A Multicenter Evaluation of Diagnosis and Management of Omega-5 Gliadin Allergy (Also Known as Wheat-Dependent Exercise-Induced Anaphylaxis) in 132 Adults.
Lucinda Kennard, Iason Thomas, K. Rutkowski, Vian Azzu +6 more
2018Journal of Allergy and Clinical Immunology: In Practice69 citations
Semantic Scholar
Rapid turnover of mitochondrial uncoupling protein 3
Vian Azzu, S. Mookerjee, M. Brand
2010Biochemical Journal58 citations Open access
Semantic Scholar
High membrane potential promotes alkenal-induced mitochondrial uncoupling and influences adenine nucleotide translocase conformation
Vian Azzu, N. Parker, M. Brand
2008Biochemical Journal52 citations Open access
Semantic Scholar
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
Gabriele Mocciaro, M. Allison, Benjamin J. Jenkins, Vian Azzu +10 more
2023Molecular Metabolism50 citations Open access
Semantic Scholar
Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome
Vian Azzu, Joshua E. Elias, A. Duckworth, S. Davies +4 more
2018Liver transplantation49 citations Open access
Semantic Scholar
Dynamic regulation of uncoupling protein 2 content in INS-1E insulinoma cells
Vian Azzu, C. Affourtit, E. Breen, N. Parker +1 more
2008Biochimica et Biophysica Acta47 citations Open access
Semantic Scholar
Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression
Vian Azzu, M. Vacca, Ioannis Kamzolas, Zoe Hall +15 more
2021Molecular Metabolism45 citations Open access
Semantic Scholar
Liver disease is common in patients with common variable immunodeficiency and predicts mortality in the presence of cirrhosis or portal hypertension.
Vian Azzu, Mariana Fonseca, A. Duckworth, Lucinda Kennard +8 more
2019Journal of Allergy and Clinical Immunology: In Practice36 citations
Semantic Scholar
Gastropericardial fistula: getting to the heart of the matter
Vian Azzu
2016BMC Gastroenterology32 citations Open access
Semantic Scholar
Making heads or tails of mitochondrial membranes in longevity and aging: a role for comparative studies
T. Valencak, Vian Azzu
2014Longevity & Healthspan25 citations Open access
Semantic Scholar
Dysregulation of glucose homeostasis in nicotinamide nucleotide transhydrogenase knockout mice is independent of uncoupling protein 2
N. Parker, A. Vidal-Puig, Vian Azzu, M. Brand
2009Biochimica et Biophysica Acta25 citations Open access
Semantic Scholar
Liver disease predicts mortality in patients with X‐linked immunodeficiency with hyper‐IgM but can be prevented by early hematopoietic stem cell transplantation
Vian Azzu, Lucinda Kennard, B. Morillo-Gutiérrez, M. Slatter +3 more
2018Journal of Allergy and Clinical Immunology15 citations Open access
Semantic Scholar
Calcium regulates scallop muscle by changing myosin flexibility
Vian Azzu, D. Yadin, Hitesh Patel, F. Fraternali +2 more
2006European Biophysics Journal9 citations Open access
Semantic Scholar
Sample size calculation for a NanoString GeoMx spatial transcriptomics experiment to study predictors of fibrosis progression in non-alcoholic fatty liver disease
Maria Ryaboshapkina, Vian Azzu
2023bioRxiv7 citations Open access
Semantic Scholar
Oxidised Apolipoprotein Peptidome Characterises Metabolic Dysfunction‐Associated Steatotic Liver Disease
Gabriele Mocciaro, Amy L George, Michael Allison, M. Frontini +8 more
2025Liver international (Print)6 citations Open access
Semantic Scholar
SMIM1 absence is associated with reduced energy expenditure and excess weight
L. Stefanucci, C. Moslemi, A. Tomé, Samuel Virtue +43 more
2024i Medicina5 citations Open access
Semantic Scholar
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
J. Cobbold, Hamish Miller, K. Hallsworth, P. Manousou +35 more
2026The Lancet Gastroenterology and Hepatology2 citations Open access
Semantic Scholar
SAT-462 First-in-human single and multiple ascending dose study of AZD2389, a potent inhibitor of fibroblast activation protein, in healthy participants to evaluate safety, tolerability, pharmacokinetics and target engagement
Vian Azzu, Samuel Daniels, Mathias Liljeblad, Tiffany Schärer +12 more
2025Journal of Hepatology1 citations
Semantic Scholar
Oxidised serum peptidome characterises metabolic dysfunction-associated steatotic liver disease.
Gabriele Mocciaro, Amy L George, Michael Allison, M. Frontini +8 more
2024Atherosclerosis1 citations
Semantic Scholar
Degradation of an intramitochondrial protein by the cytosolic proteasome
Vian Azzu, M. Brand
2010Journal of Cell Science1 citations Open access
Semantic Scholar
A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis
A. Sanyal, Michelle T. Long, N. Obuchowski, Roberto A Calle +26 more
2026Nature Medicine0 citations
Semantic Scholar
FRI-148 Pharmacodynamics, pharmacokinetics, safety, and tolerability of AZD2389, a fibroblast activation protein inhibitor in participants with liver fibrosis and compensated cirrhosis
Vian Azzu, Samuel Daniels, Mathias Liljeblad, M. Niazi +12 more
2026Journal of Hepatology0 citations
Semantic Scholar
FRI-172 Imaging of Fibroblast Activation Protein: AZD2389 demonstrates liver target occupancy in participants with advanced chronic liver disease
Mathias Liljeblad, Zsolt Cseleny, David Janzen, M. Niazi +8 more
2026Journal of Hepatology0 citations
Semantic Scholar
Non-alcoholic fatty liver disease features a reduced reverse polyunsaturated fatty acid transport (free fatty acids/high-density lipoprotein) from the periphery to the liver
Gabriele Mocciaro, M. Allison, Benjamin J. Jenkins, Vian Azzu +9 more
2022Journal of Hepatology0 citations
Semantic Scholar
Loss of function variant in SMIM1 is associated with reduced energy expenditure and weight gain
M. Frontini, L. Stefanucci, C. Moslemi, A. Tome +35 more
20220 citations Open access
Semantic Scholar
A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD
O. Govaere, S. McPherson, R. Younes, D. Tiniakos +17 more
2020Journal of Hepatology0 citations Open access
Semantic Scholar
Reply.
Vian Azzu, Mariana Fonseca, Lucinda Kennard, A. Duckworth +8 more
2019Journal of Allergy and Clinical Immunology: In Practice0 citations
Semantic Scholar
Deactivation of mitochondrial uncoupling proteins
Vian Azzu
20090 citations
Semantic Scholar
Malaria vaccine holds out eradication hope
Vian Azzu
20090 citations
Semantic Scholar
Special report: swine flu's second wave
Vian Azzu
20090 citations
Semantic Scholar
S12.9 Dynamic regulation of UCP2 concentration in INS-1E pancreatic beta-cells
Vian Azzu, C. Affourtit, E. Breen, N. Parker +1 more
20080 citations Open access
Semantic Scholar

Lucinda Kennard

×4

N. Parker×4

Gabriele Mocciaro×4

I. Huang-Doran×4

D. Kumararatne×4

M. Vacca×3

S. Virtue×3

D. Susan×3